Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 822 results for "hcv"

Bristol-Myers Hepatitis C Therapy Approved in EU

Bristol-Myers Squibb (NYSE: BMY ) won approval for its oral hepatitis C virus (HCV) drug Daklinza in the European Union Wednesday, as the company continued to carve out a niche in the increasingly competitive HCV space. The EU approved Daklinza ... Investor's Business Daily, 9 hours ago

38 images for hcv

Hepatology, 5 days ago
Project Inform, 1 week ago
ABC News 4 Charleston, 2 days ago
Malaysia MSN, 1 week ago
AME Info, 2 weeks ago
Clinical Lab Products, 3 weeks ago
agoramedia.com, 2 weeks ago
Asian Scientist, 3 weeks ago
Valley Gazette, 2 weeks ago
BlackDoctor.org, 2 weeks ago
SPi World News

Achillion announces encouraging interim results from Phase II HCV study

Achillion Pharmaceuticals, Inc. has announced encouraging interim results from an ongoing Phase II proxy study evaluating ACH-3102, its second-generation NS5A inhibitor, in combination with sofosbuvir, without ribavirin, for eight weeks of treatment ...
 Individual.com12 hours ago Promising Results With Achillion's Ribavirin-Free HCV Regimen  American Journal of Managed Care1 week ago Achillion Pharma's ACH-3102 and structurally related NS5A inhibitors receives US patent  PharmaBiz4 days ago Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors  Stockwatch1 week ago
[x]  

Bristol-Myers Squibb (BMY) Receives EC Approval of Daklinza as HCV Treatment

Visit StreetInsider.com at http://www.streetinsider.com/news.php-st=p&id=9785537 for the
 TVNewsCheck14 hours ago Turbocharger Market by Vehicle Type (Passenger Car, LCV & HCV), Fuel Type (Diesel & Gasoline), Technology (VGT/VNT, Wastegate & Twin-Turbo), & Region - Industry Trends & Forecasts to 2019  Securities Technology Monitor2 days ago
[x]  

Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data

Achillion Pharmaceuticals, Inc. ( ACHN ) reported positive interim results from a phase II study (n=12) on its hepatitis C virus (:HCV) candidate, ACH-3102. The company's shares jumped 9.6% following the news. The mid-stage study is evaluating a ...
 Yahoo! Finance1 week ago Achillion's HCV Drug Cures All Patients in Mid-stage Trial  Diabetes Care1 week ago
[x]  

Nearly Half Of Surveyed Specialists Expect To Prescribe Gilead's Sofosbuvir/Ledipasvir Regimen Near-Term For Hepatitis C Infections

BURLINGTON, Mass. Other key findings from the report entitled : Current treatment of HCV: Six months after the launch of Sovaldi, the shift in treatment paradigm is evident; Sovaldi-containing regimens lead the pack across key genotypes, ...
 TheStreet.com1 week ago ION-2: High rates of response to sofosbuvir/ledipasvir  Orthopedics Today6 days ago Sofosbuvir/ledipasvir expected to gain market share  Orthopedics Today1 week ago
Scottrade

upgrading India's infrastructure will be a priority for the government to speed up the demand for goods carriers in the M&HCV segments

Massive urbanization will drive the growth of the LCV segment in India. The new government will focus on urbanization as an opportunity and create 100 more urban cities over the next 5 years. Urban consumption will be key to the 6.8% CAGR from ...
 TransWorldNews5 days ago International Antiviral Therapeutics Report 2014-Technologies, Markets and Companies (Updated)  IndiaPRwire2 days ago Forecast of the Indian Commercial Vehicles (CV) Market 2014-2020  Individual.com1 week ago Research and Markets: Forecast of the Indian Commercial Vehicles (CV) Market 2014-2020  TeleTrader.com1 week ago
[x]  
Med India

Increased plasma concentration of ribavirin as a result of renal dysfunction in hepatitis C virus patients treated with telaprevir

Download the PDF here Hepatology July 28 2014 To the Editor: Pronounced anemia is observed in hepatitis C virus (HCV) patients treated with a triple therapy containing ribavirin (RBV), pegylated interferon (Peg-IFN), and telaprevir (TLV), ...
 National AIDS Treatment Advocacy Project4 days ago Study Identifies Hepatitis C Virus Genotype 1 as the Most Prevalent Worldwide  Med India1 month ago J&K govt sanctions medicine procurement for anti Hepatitis-C  Business Standard1 month ago Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C....... "treat all"  National AIDS Treatment Advocacy Project2 days ago

Automotive Multi-Wheel Drive Systems Market $6,247.5 Million by 2019

The report "Automotive Multi-Wheel Drive Systems Market by Vehicle Type (Passenger Car, LCV and HCV), by System Type (Automatic AWD and Manual AWD Systems) & by Geography (Asia-Oceania, North America, Europe and ROW) - Global Trends and Forecast to ...
 Wall Street Select6 days ago Global AWD Systems Market Gaining Demand for Multi-Wheel Drive Says...  PRWeb4 days ago MarketsandMarkets Brings Out Report on Automotive Telematics Market [Travel & Leisure Close - Up]  TMC Net20 hours ago MarketsandMarkets Releases Report on Automotive Multi-Wheel Drive Systems Market  Individual.com1 day ago
[x]  

Enanta Pharmaceuticals' HCV NS5A Inhibitor EDP-239 Advances into Combination Studies with Alisporivir DEB025

By a News Reporter-Staff News Editor at Pharma Business Week Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced ...
 Pharmacy Choice1 week ago Enanta Pharmaceuticals : Patent Issued for Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors  4 Traders2 hours ago Oswaldo Cruz Institute Details Findings in Hepatitis (Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations)  4 Traders5 hours ago Enanta Pharmaceuticals to Present at Three Upcoming Investor Conferences  BioSpace5 hours ago
[x]  

CDC Shares Resources on the Risks of Healthcare-associated Infections from Drug Diversion

Aids.gov: Quality health care is safe health care; neither patients nor providers should be at risk for acquiring HBV, HCV, or other bloodborne infections during health care encounters. Viral hepatitis stakeholders recognize that such health ...
 I360 Gov1 day ago Political Cartoon: 'Admission Against Interest?'  Kaiser Health News1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less